ConductScience.org, home

Paper21317876

IL-10 expression by primary tumor cells correlates with melanoma progression from radial to vertical growth phase and development of metastatic competence.

Itakura E and 5 others. Mod Pathol, 2011. Cited by 139 papers, by iCite.

Cite this record

ConductScience Library. IL-10 expression by primary tumor cells correlates with melanoma progression from radial to vertical growth phase and development of metastatic competence. Papers, record 21317876. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/21317876

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
IL-10 expression by primary tumor cells correlates with melanoma progression from radial to vertical growth phase and development of metastatic competence.
PubMed
Journal
Mod Pathol
PubMed
Year
2011
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural
PubMed
Citations, by iCite
139
iCite
Relative citation ratio, by iCite
3.21
iCite
Revised in PubMed
2025-05-29
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Itakura EEijun
2Huang RRRong-Rong
3Wen DRDuan-Ren
4Paul EEberhard
5Wünsch PHPeter H
6Cochran AJAlistair J

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Interleukin-10Major topic
MelanomaMajor topic
Skin NeoplasmsMajor topic
Biomarkers, Tumor
Disease Progression
Gene Expression Regulation, Neoplastic
Humans
Lymphocytes, Tumor-Infiltrating
Neoplasm Invasiveness
Nevus, Pigmented
RNA, Messenger

Source PubMed

Download CSV of topics

Grants2

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
P01 CA029605NCI NIH HHSUnited StatesP01CA029605PubMed and NIH
P01 CA 29605NCI NIH HHSUnited StatesP01CA029605PubMed and NIH

Source NIH RePORTER

Download CSV of grants

References43

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
17981073Expression of interleukin 10 in human melanoma.Br J Cancer1994https://conductscience.org/library/papers/7981073PubMed
218643844Immune modulation by melanoma-derived factors.Exp Dermatol2008https://conductscience.org/library/papers/18643844PubMed
315671534Quantitative analysis of melanoma-induced cytokine-mediated immunosuppression in melanoma sentinel nodes.Clin Cancer Res2005https://conductscience.org/library/papers/15671534PubMed
49646029Detection of tyrosinase mRNA in formalin-fixed, paraffin-embedded archival sections of melanoma, using the reverse transcriptase in situ polymerase chain reaction.Diagn Mol Pathol1998https://conductscience.org/library/papers/9646029PubMed
517545514Molecular characterization of inflammatory genes in sentinel and nonsentinel nodes in melanoma.Clin Cancer Res2007https://conductscience.org/library/papers/17545514PubMed
618204435RT in situ PCR detection of MART-1 and TRP-2 mRNA in formalin-fixed, paraffin-embedded tissues of melanoma and nevi.Mod Pathol2008https://conductscience.org/library/papers/18204435PubMed
717565341Mechanisms of local immunosuppression in cutaneous melanoma.Br J Cancer2007https://conductscience.org/library/papers/17565341PubMed
815240741Foxp3 expressing CD4+CD25(high) regulatory T cells are overrepresented in human metastatic melanoma lymph nodes and inhibit the function of infiltrating T cells.J Immunol2004https://conductscience.org/library/papers/15240741PubMed
912325512RT-PCR-based approaches to generate probes for mRNA detection by in situ hybridization.Methods Mol Biol2002https://conductscience.org/library/papers/12325512PubMed
1012490959Inflammation and cancer.Nature2002https://conductscience.org/library/papers/12490959PubMed
1110629075Macrophage infiltration correlates with tumor stage and angiogenesis in human malignant melanoma: possible involvement of TNFalpha and IL-1alpha.Int J Cancer2000https://conductscience.org/library/papers/10629075PubMed
1216932751Tumour-induced immune modulation of sentinel lymph nodes.Nat Rev Immunol2006https://conductscience.org/library/papers/16932751PubMed
138647620Interleukin-10 production in malignant melanoma: preferential detection of IL-10-secreting tumor cells in metastatic lesions.Int J Cancer1996https://conductscience.org/library/papers/8647620PubMed
1410570177Ligation of intestinal epithelial CD1d induces bioactive IL-10: critical role of the cytoplasmic tail in autocrine signaling.Proc Natl Acad Sci U S A1999https://conductscience.org/library/papers/10570177PubMed
1512477722Comprehensive proteomic analysis of breast cancer cell membranes reveals unique proteins with potential roles in clinical cancer.J Biol Chem2003https://conductscience.org/library/papers/12477722PubMed
1611477657Detection of three novel translocations and specific common chromosomal break sites in malignant melanoma by spectral karyotyping.Genes Chromosomes Cancer2001https://conductscience.org/library/papers/11477657PubMed
1714585195Increased interleukin-10 mRNA stability in melanoma cells is associated with decreased levels of A + U-rich element binding factor AUF1.J Interferon Cytokine Res2003https://conductscience.org/library/papers/14585195PubMed
189605762Chromosomal gains and losses in primary cutaneous melanomas detected by comparative genomic hybridization.Cancer Res1998https://conductscience.org/library/papers/9605762PubMed
1912710945Detection of multiple melanoma-associated markers in melanoma cell lines by RT in situ PCR.Exp Mol Pathol2003https://conductscience.org/library/papers/12710945PubMed
2010970683Soluble interleukin-2 receptor, intercellular adhesion molecule-1 and interleukin-10 serum levels in patients with melanoma.Br J Cancer2000https://conductscience.org/library/papers/10970683PubMed

See all 43 referencesDownload CSV of references

Cited by98

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 139 citations.

PMIDTitleJournalYearIn PapersSource
42375809Crosstalk in the brain tumor microenvironment: mechanisms, therapeutic strategies, and clinical advances.Mil Med Res2026https://conductscience.org/library/papers/42375809PubMed
42195213Circulating Cytokines in Melanoma Prognosis: Current Evidence and Future Perspectives.Medicina (Kaunas)2026https://conductscience.org/library/papers/42195213PubMed
42075611Uncovering the Intricate and Heterogeneous Cellular Microenvironment of Cutaneous Melanoma.Medicina (Kaunas)2026https://conductscience.org/library/papers/42075611PubMed
41816687Bacterial colonized melanoma skin models allow to study host-microbe interactions in situ.Front Microbiol2026https://conductscience.org/library/papers/41816687PubMed
41745410Cytokine Profiling in Cutaneous Melanoma: The Emerging Role of Interleukins in Prognostic Stratification with an Up-to-Date Overview of Published Data.J Pers Med2026https://conductscience.org/library/papers/41745410PubMed
41744822Development of a 3D Skin Model for Studying Melanoma Progression.Cells2026https://conductscience.org/library/papers/41744822PubMed
41742891Tertiary lymphoid structures guided opportunities and challenges for immunotherapy in early gastroesophageal junction cancer and low rectal cancer.Hum Vaccin Immunother2026https://conductscience.org/library/papers/41742891PubMed
41719156The insider's perspective: The intracellular complosome and immune cell dynamics in cancer.Clin Transl Med2026https://conductscience.org/library/papers/41719156PubMed
41627569Modelling Immune Dynamics in Locally Advanced MSI-H/dMMR Colorectal Cancer with Neoadjuvant Pembrolizumab Treatment: From Differential Equations to an Agent-Based Framework.Bull Math Biol2026https://conductscience.org/library/papers/41627569PubMed
41407207Modulating tumor mechanics and vascular barriers to enhance chemotherapy efficacy in pancreatic tumors and melanoma.J Control Release2026https://conductscience.org/library/papers/41407207PubMed
41020868Serum TNF -α, IL-10 and IL-2 Trajectories and Outcomes in NSCLC and Melanoma Under Anti-PD-1 Therapy: Longitudinal Real-World Evidence from a Single Center.Curr Issues Mol Biol2025https://conductscience.org/library/papers/41020868PubMed
41019059The immunomodulatory and antitumor properties of the bacterial metalloprotease Oligopeptidase A are mediated by TLR4/MyD88/TRIF and MAPK signaling pathways.Front Immunol2025https://conductscience.org/library/papers/41019059PubMed
40951575Immune Boosters and Immunotherapy in Allergic Diseases and in Cancer Management.Arch Razi Inst2025https://conductscience.org/library/papers/40951575PubMed
40841319Davanat-Mimetic Galactomannan and Its Sulfated Derivative: Structure and Antitumor Effects against Melanoma.Biomacromolecules2025https://conductscience.org/library/papers/40841319PubMed
40672947Modulation of the immune microenvironment using nanomaterials: a new strategy for tumor immunotherapy.Front Immunol2025https://conductscience.org/library/papers/40672947PubMed
40620536Macrophage respiratory complex III governs immune evasion.Immunometabolism (Cobham)2025https://conductscience.org/library/papers/40620536PubMed
40301712PYGO2 regulates IL10 and plays immunosuppressive role through ESCC progression.BMC Mol Cell Biol2025https://conductscience.org/library/papers/40301712PubMed
40283387Unexpectedly High and Difficult-to-Explain Regenerative Capacity in an 82-Year-Old Patient with Insulin-Requiring Type 2 Diabetes and End-Stage Renal Disease.J Clin Med2025https://conductscience.org/library/papers/40283387PubMed
40149345IL-10-Directed Cancer Immunotherapy: Preclinical Advances, Clinical Insights, and Future Perspectives.Cancers (Basel)2025https://conductscience.org/library/papers/40149345PubMed
39841829Mitochondrial respiratory complex III sustains IL-10 production in activated macrophages and promotes tumor-mediated immune evasion.Sci Adv2025https://conductscience.org/library/papers/39841829PubMed

See all 98 cited byDownload CSV of cited by

Genes5

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
IL103586PubTator's text mininghttps://conductscience.org/library/genes/3586NCBI Gene
IL12B3593PubTator's text mininghttps://conductscience.org/library/genes/3593NCBI Gene
IL23558PubTator's text mininghttps://conductscience.org/library/genes/3558NCBI Gene
IL2RA3559PubTator's text mininghttps://conductscience.org/library/genes/3559NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/21317876

GET https://conductscience.org/api/papers/v1/21317876/references?page=2